Current Perspectives: Evidence to Date on BTK Inhibitors in the Management of Multiple Sclerosis

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system leading to demyelination and neurodegeneration. Basic and translational studies have shown that B cells and myeloid cells are critical players for the development and course of the disease. Bruton’s tyrosine kina...

Descripción completa

Detalles Bibliográficos
Autores principales: Carnero Contentti, Edgar, Correale, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553159/
https://www.ncbi.nlm.nih.gov/pubmed/36238195
http://dx.doi.org/10.2147/DDDT.S348129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553159/
https://www.ncbi.nlm.nih.gov/pubmed/36238195
http://dx.doi.org/10.2147/DDDT.S348129

Ejemplares similares